Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
Certain HCPs can be challenged with limited resources and access to the latest science on IBD treatments. Programs aimed at reaching healthcare practitioners in these areas to provide education on IBD management and guidelines will be considered.
The intent of this RFP is to encourage organizations to design educational programs to reach nurses, nurse practitioners and physician assistants that care for patients with IBD.
Grant Application due date: October 18, 2019
Geographic Scope: United States
• The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. all institutions must have a relevant role and the requesting organization must have a key role in the project. • For projects offering continuing education credit, the requesting organization must be accredited.
Individual projects requesting up to $250,000 will be considered. Up to 4 projects will be selected for funding.
